TENECTEPLASE

TENECTEPLASE was reported 1600 times

TENECTEPLASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT MIDDLE CEREBRAL ARTERY SYNDROME 2 0.4000
1 CEREBRAL ARTERY PERFORATION 3 0.3750
2 VERTEBROBASILAR INFARCTION 1 0.2000
3 FIBRIN DECREASED 2 0.1818
4 THALAMIC MICROHAEMORRHAGE 1 0.1667
5 HAEMORRHAGIC THYROID CYST 2 0.1667
6 FIBRINOGEN DEGRADATION PRODUCTS INCREASED 1 0.1111
7 PERIPHERAL VASCULAR HAEMATOMA 2 0.1111
8 JUGULAR VEIN HAEMORRHAGE 1 0.0909
9 SPINAL EPIDURAL HAEMORRHAGE 6 0.0741
10 NIH STROKE SCALE SCORE INCREASED 6 0.0723
11 DECOMPRESSIVE CRANIECTOMY 2 0.0714
12 SPINAL SHOCK 5 0.0685
13 CORNEAL LIGHT REFLEX TEST ABNORMAL 1 0.0588
14 CEREBRAL MICROINFARCTION 3 0.0517
15 STROKE IN EVOLUTION 10 0.0450
16 HAEMORRHAGIC TRANSFORMATION STROKE 61 0.0405
17 SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE 3 0.0357
18 VASCULAR ACCESS SITE EXTRAVASATION 3 0.0345
19 INTESTINAL POLYP HAEMORRHAGE 1 0.0333
20 REPERFUSION ARRHYTHMIA 2 0.0328
21 NIH STROKE SCALE ABNORMAL 1 0.0323
22 THROMBOLYSIS 7 0.0315
23 DIABETIC MACROANGIOPATHY 1 0.0303
24 POST STROKE SEIZURE 1 0.0294
25 HAEMORRHAGE CORONARY ARTERY 2 0.0278
26 MYOCARDIAL REPERFUSION INJURY 1 0.0263
27 HAEMOSTASIS 4 0.0245
28 VASCULAR ACCESS SITE HAEMATOMA 1 0.0238
29 AORTIC INTRAMURAL HAEMATOMA 3 0.0231
30 CEREBRAL MASS EFFECT 8 0.0220
31 INTRAOCULAR HAEMATOMA 1 0.0200
32 ARTERIAL PERFORATION 1 0.0200
33 RETENTION CYST 1 0.0196
34 ORBITAL COMPARTMENT SYNDROME 1 0.0182
35 BLOOD FIBRINOGEN ABNORMAL 1 0.0175
36 SPINAL EPIDURAL HAEMATOMA 10 0.0170
37 AGNOSIA 4 0.0168
38 COMA SCALE 1 0.0164
39 THYROID HAEMORRHAGE 1 0.0152
40 ATHEROEMBOLISM 2 0.0148
41 CEREBELLAR HAEMATOMA 4 0.0142
42 BLOOD PRESSURE SYSTOLIC 1 0.0135
43 REOCCLUSION 1 0.0128
44 HAEMORRHAGIC INFARCTION 7 0.0128
45 CARDIAC REHABILITATION THERAPY 1 0.0127
46 PSEUDOBULBAR PALSY 1 0.0127
47 NEUROLOGICAL DECOMPENSATION 29 0.0125
48 POST PROCEDURAL MYOCARDIAL INFARCTION 1 0.0123
49 OESOPHAGEAL COMPRESSION 1 0.0123
50 LYMPHOCYTIC LYMPHOMA 1 0.0120
51 VISUOSPATIAL DEFICIT 1 0.0110
52 TONGUE HAEMATOMA 2 0.0101
53 SPINAL CORD HAEMORRHAGE 4 0.0100
54 HAEMORRHAGIC CEREBRAL INFARCTION 7 0.0100
55 MYOCARDIAL RUPTURE 3 0.0098
56 CARDIAC INDEX DECREASED 1 0.0097
57 CAROTID ARTERY ATHEROMA 1 0.0094
58 SUBCAPSULAR RENAL HAEMATOMA 2 0.0094
59 INTRACRANIAL HAEMATOMA 5 0.0089
60 BASAL GANGLIA INFARCTION 3 0.0087
61 EXTRAVASATION BLOOD 2 0.0084
62 PURPURA SENILE 1 0.0082
63 CORONARY ARTERY PERFORATION 1 0.0081
64 HAEMORRHAGE INTRACRANIAL 118 0.0079
65 PENILE CANCER 1 0.0076
66 QUADRANTANOPIA 1 0.0076
67 VENTRICLE RUPTURE 1 0.0074
68 OCULAR RETROBULBAR HAEMORRHAGE 1 0.0072
69 NEUROLOGIC NEGLECT SYNDROME 4 0.0072
70 HAEMATOMA EVACUATION 2 0.0071
71 CEREBELLAR INFARCTION 12 0.0071
72 OROPHARYNGEAL OEDEMA 1 0.0069
73 INTRAVENTRICULAR HAEMORRHAGE 17 0.0068
74 ACCELERATED IDIOVENTRICULAR RHYTHM 1 0.0068
75 CORONARY REVASCULARISATION 1 0.0063
76 BASILAR ARTERY OCCLUSION 1 0.0060
77 CORONARY ARTERY DISSECTION 5 0.0058
78 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 2 0.0057
79 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 1 0.0057
80 CEREBRAL ARTERY OCCLUSION 6 0.0056
81 BRAIN STEM ISCHAEMIA 1 0.0056
82 RENAL EMBOLISM 1 0.0054
83 ARTERIOVENOUS FISTULA SITE HAEMORRHAGE 1 0.0053
84 DEHISCENCE 1 0.0053
85 BRAIN STEM HAEMORRHAGE 5 0.0053
86 AORTIC RUPTURE 2 0.0052
87 DOSE CALCULATION ERROR 3 0.0051
88 PERICARDIAL HAEMORRHAGE 11 0.0050
89 BRAIN HERNIATION 15 0.0050
90 PLEURAL ADHESION 1 0.0050
91 VERTEBRAL ARTERY DISSECTION 1 0.0049
92 CEREBRAL HAEMATOMA 16 0.0048
93 ANAL SPHINCTER ATONY 2 0.0047
94 SUBARACHNOID HAEMORRHAGE 47 0.0046
95 ARTERIAL REPAIR 1 0.0046
96 CEREBRAL HAEMORRHAGE 162 0.0045
97 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 1 0.0044
98 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 2 0.0043
99 TRAUMATIC LIVER INJURY 1 0.0043
100 ELECTROCARDIOGRAM Q WAVE ABNORMAL 1 0.0043
101 CEREBELLAR HAEMORRHAGE 6 0.0042
102 TRANSIENT GLOBAL AMNESIA 3 0.0042
103 CEREBRAL ARTERY EMBOLISM 5 0.0041
104 CHOLESTEROSIS 1 0.0039
105 ADAMTS13 ACTIVITY DECREASED 1 0.0039
106 ABDOMINAL WALL HAEMORRHAGE 1 0.0038
107 HAEMOPERITONEUM 3 0.0037
108 PRODUCT NAME CONFUSION 4 0.0037
109 PERIORBITAL HAEMATOMA 3 0.0036
110 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
111 BRAIN SCAN ABNORMAL 2 0.0036
112 SPLENIC HAEMATOMA 1 0.0035
113 AGONAL RESPIRATION 1 0.0035
114 BLOOD FIBRINOGEN DECREASED 4 0.0035
115 HEPATIC HAEMORRHAGE 3 0.0035
116 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG 1 0.0034
117 VASCULAR STENT THROMBOSIS 7 0.0034
118 CATHETER SITE HAEMATOMA 1 0.0034
119 CORONARY ARTERY EMBOLISM 1 0.0034
120 CARDIAC FUNCTION TEST ABNORMAL 1 0.0034
121 INCREASED DOSE ADMINISTERED 1 0.0032
122 LOSS OF PROPRIOCEPTION 1 0.0031
123 THROMBECTOMY 1 0.0031
124 INTERCEPTED PRODUCT STORAGE ERROR 11 0.0031
125 HYPOFIBRINOGENAEMIA 3 0.0030
126 CARDIAC ANEURYSM 3 0.0030
127 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 10 0.0030
128 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
129 PULMONARY NECROSIS 1 0.0029
130 CAROTID ARTERY ANEURYSM 1 0.0029
131 SPONTANEOUS HAEMORRHAGE 3 0.0029
132 MENINGITIS VIRAL 4 0.0029
133 ANGIOEDEMA 129 0.0029
134 ANASTOMOTIC COMPLICATION 1 0.0029
135 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
136 PRODUCT DOSE CONFUSION 1 0.0028
137 FAT EMBOLISM 1 0.0028
138 VASOGENIC CEREBRAL OEDEMA 2 0.0028
139 GLASGOW COMA SCALE ABNORMAL 1 0.0028
140 WEANING FAILURE 1 0.0027
141 RESPIRATORY TRACT OEDEMA 2 0.0027
142 HAEMORRHAGIC STROKE 21 0.0027
143 CORNEAL REFLEX DECREASED 1 0.0027
144 HEART SOUNDS ABNORMAL 2 0.0027
145 ANISOCORIA 1 0.0026
146 PUPILS UNEQUAL 3 0.0026
147 ELECTROCARDIOGRAM QRS COMPLEX SHORTENED 1 0.0026
148 PRODUCT BARCODE ISSUE 1 0.0026
149 MUCOSAL HAEMORRHAGE 3 0.0026
150 CEREBRAL ARTERIOSCLEROSIS 1 0.0026
151 WRONG DRUG ADMINISTERED 23 0.0026
152 TONGUE HAEMORRHAGE 3 0.0026
153 BRAIN COMPRESSION 1 0.0025
154 SPUTUM CULTURE POSITIVE 2 0.0025
155 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 2 0.0025
156 AMPUTATION 3 0.0024
157 STRIDOR 7 0.0024
158 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
159 CARDIOGENIC SHOCK 34 0.0024
160 THALAMUS HAEMORRHAGE 2 0.0023
161 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
162 BILIARY SEPSIS 1 0.0022
163 INTERCEPTED MEDICATION ERROR 10 0.0022
164 NEUROLOGICAL EXAMINATION ABNORMAL 1 0.0021
165 PULMONARY VASCULAR DISORDER 1 0.0021
166 MYELOPATHY 4 0.0021
167 PHARYNGEAL DISORDER 6 0.0021
168 HAEMOTHORAX 6 0.0021
169 CEREBRAL ARTERY STENOSIS 1 0.0020
170 ARTERIOVENOUS FISTULA 1 0.0020
171 BRAIN STEM STROKE 1 0.0020
172 INTRAOCULAR LENS IMPLANT 1 0.0020
173 CATHETER SITE HAEMORRHAGE 5 0.0020
174 SUPRAPUBIC PAIN 1 0.0020
175 SPLENIC HAEMORRHAGE 1 0.0020
176 CEREBRAL ARTERY THROMBOSIS 1 0.0019
177 VASCULAR OCCLUSION 4 0.0019
178 ENZYME ABNORMALITY 1 0.0019
179 THROMBOSIS IN DEVICE 6 0.0018
180 PRODUCT CLOSURE ISSUE 1 0.0018
181 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0018
182 NO ADVERSE EVENT 316 0.0017
183 TREATMENT DELAYED 3 0.0017
184 PUPIL FIXED 3 0.0017
185 RIGHT VENTRICULAR DILATATION 1 0.0017
186 EJECTION FRACTION 1 0.0017
187 ISCHAEMIC CEREBRAL INFARCTION 2 0.0017
188 HEMIPARESIS 29 0.0017
189 THALAMIC INFARCTION 1 0.0017
190 LABILE BLOOD PRESSURE 2 0.0017
191 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
192 CARDIAC TAMPONADE 8 0.0017
193 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
194 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
195 GRUNTING 1 0.0017
196 HAEMATOMA MUSCLE 2 0.0017
197 EMBOLISM ARTERIAL 2 0.0017
198 PULMONARY HAEMORRHAGE 13 0.0017
199 DYSMETRIA 1 0.0017
200 CARDIAC PROCEDURE COMPLICATION 1 0.0016
201 PUPILLARY REFLEX IMPAIRED 3 0.0016
202 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
203 ARTERIAL THROMBOSIS 3 0.0016
204 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
205 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
206 EXTRADURAL HAEMATOMA 2 0.0015
207 EMBOLIC CEREBRAL INFARCTION 1 0.0015
208 BRAIN OEDEMA 19 0.0015
209 CORONARY ARTERY THROMBOSIS 3 0.0015
210 VENTRICULAR FIBRILLATION 16 0.0014
211 LEIOMYOMA 1 0.0014
212 PERIPHERAL ARTERY THROMBOSIS 2 0.0014
213 PUNCTURE SITE HAEMORRHAGE 1 0.0014
214 ISCHAEMIC STROKE 25 0.0014
215 PRODUCT DESIGN ISSUE 1 0.0014
216 COMA SCALE ABNORMAL 4 0.0014
217 APALLIC SYNDROME 1 0.0014
218 BRAIN CONTUSION 1 0.0014
219 HEMIANOPIA HOMONYMOUS 1 0.0014
220 THROMBOTIC STROKE 1 0.0014
221 SERRATIA INFECTION 1 0.0013
222 BRAIN STEM SYNDROME 1 0.0013
223 BRAIN DEATH 4 0.0013
224 HYDROCEPHALUS 7 0.0013
225 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
226 ELECTROMECHANICAL DISSOCIATION 1 0.0013
227 INCISION SITE HAEMORRHAGE 1 0.0012
228 BASAL GANGLIA HAEMORRHAGE 1 0.0012
229 PENILE HAEMORRHAGE 1 0.0012
230 HEPARIN-INDUCED THROMBOCYTOPENIA 6 0.0012
231 AORTIC DISSECTION 5 0.0012
232 PULSELESS ELECTRICAL ACTIVITY 5 0.0012
233 CEREBRAL INFARCTION 29 0.0012
234 POST PROCEDURAL HAEMATOMA 2 0.0012
235 CAROTID ARTERY THROMBOSIS 1 0.0012
236 OESOPHAGEAL OBSTRUCTION 1 0.0012
237 VASCULAR PSEUDOANEURYSM 2 0.0011
238 FACIAL PARESIS 4 0.0011
239 UPPER AIRWAY OBSTRUCTION 1 0.0011
240 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
241 HEART TRANSPLANT 1 0.0011
242 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
243 INTESTINAL INFARCTION 1 0.0011
244 SUBDURAL HAEMORRHAGE 3 0.0011
245 ANEURYSM RUPTURED 1 0.0011
246 VASOSPASM 1 0.0011
247 PRODUCT PREPARATION ISSUE 7 0.0011
248 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
249 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
250 INFARCTION 7 0.0010
251 VENOUS THROMBOSIS 4 0.0010
252 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 9 0.0010
253 HEMIANOPIA 1 0.0010
254 PNEUMONIA ASPIRATION 25 0.0010
255 HYPERCAPNIA 3 0.0010
256 CORONARY ARTERY STENOSIS 5 0.0010
257 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
258 BRAIN STEM INFARCTION 1 0.0010
259 CAROTID ARTERIOSCLEROSIS 1 0.0010
260 ALVEOLITIS ALLERGIC 1 0.0010
261 MYOCARDIAL ISCHAEMIA 11 0.0010
262 LIVEDO RETICULARIS 2 0.0010
263 SYSTOLIC DYSFUNCTION 1 0.0009
264 BLOOD SODIUM ABNORMAL 1 0.0009
265 HAEMATOMA 24 0.0009
266 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
267 PRODUCT SELECTION ERROR 1 0.0009
268 NEPHROSCLEROSIS 1 0.0009
269 POTENTIATING DRUG INTERACTION 3 0.0009
270 MYOCARDIAL INJURY 1 0.0009
271 SURGICAL FAILURE 1 0.0009
272 CAROTID ARTERY STENOSIS 3 0.0009
273 PRODUCT LABEL CONFUSION 5 0.0009
274 EMBOLIC STROKE 3 0.0009
275 HYPERTENSIVE EMERGENCY 1 0.0008
276 APHASIA 25 0.0008
277 PRODUCT PACKAGING CONFUSION 2 0.0008
278 PANCREATIC NEOPLASM 1 0.0008
279 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
280 SNORING 3 0.0008
281 TROPONIN T INCREASED 1 0.0008
282 LIP HAEMORRHAGE 1 0.0008
283 SUBCUTANEOUS HAEMATOMA 1 0.0008
284 PRODUCT PREPARATION ERROR 16 0.0008
285 HAEMORRHAGE 81 0.0008
286 COMPARTMENT SYNDROME 2 0.0008
287 PETECHIAE 8 0.0008
288 OESOPHAGEAL HAEMORRHAGE 1 0.0008
289 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
290 AREFLEXIA 2 0.0007
291 MUSCLE HAEMORRHAGE 3 0.0007
292 MEDICATION ERROR 40 0.0007
293 INTRACRANIAL PRESSURE INCREASED 4 0.0007
294 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
295 CULTURE URINE POSITIVE 1 0.0007
296 LIP OEDEMA 3 0.0007
297 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
298 INTENSIVE CARE 1 0.0007
299 FACIAL PARALYSIS 6 0.0007
300 ANURIA 6 0.0007
301 HAEMATEMESIS 17 0.0007
302 CEREBROVASCULAR DISORDER 2 0.0007
303 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
304 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
305 RUBBER SENSITIVITY 1 0.0007
306 ISCHAEMIA 3 0.0007
307 INTERCEPTED PRODUCT PREPARATION ERROR 8 0.0006
308 DIASTOLIC DYSFUNCTION 2 0.0006
309 TRANSCRIPTION MEDICATION ERROR 1 0.0006
310 OPHTHALMOPLEGIA 1 0.0006
311 INTERMITTENT CLAUDICATION 1 0.0006
312 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
313 SUBDURAL HAEMATOMA 9 0.0006
314 STUPOR 2 0.0006
315 ACUTE MYOCARDIAL INFARCTION 18 0.0006
316 SPLENIC RUPTURE 1 0.0006
317 INJECTION RELATED REACTION 1 0.0006
318 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
319 CYTOLYTIC HEPATITIS 2 0.0006
320 POST PROCEDURAL HAEMORRHAGE 7 0.0006
321 VEIN RUPTURE 1 0.0006
322 WRONG PRODUCT ADMINISTERED 4 0.0006
323 LEUKAEMIA RECURRENT 1 0.0006
324 EYE MOVEMENT DISORDER 4 0.0006
325 CEREBRAL ISCHAEMIA 3 0.0006
326 SKIN NECROSIS 3 0.0006
327 INFUSION SITE DISCHARGE 1 0.0006
328 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
329 FIBRIN D DIMER INCREASED 2 0.0006
330 PARAPARESIS 1 0.0006
331 ASPIRATION 6 0.0005
332 STENOSIS 1 0.0005
333 TRAUMATIC HAEMORRHAGE 1 0.0005
334 NEUROLOGICAL SYMPTOM 3 0.0005
335 TONGUE OEDEMA 2 0.0005
336 WOUND SECRETION 2 0.0005
337 UNDERWEIGHT 1 0.0005
338 SENSORY LOSS 4 0.0005
339 PERIPHERAL ISCHAEMIA 2 0.0005
340 ANAPHYLACTOID REACTION 2 0.0005
341 RENAL MASS 1 0.0005
342 VENOUS THROMBOSIS LIMB 1 0.0005
343 ATRIAL THROMBOSIS 1 0.0005
344 HEMIPLEGIA 4 0.0005
345 TRANSFUSION 5 0.0005
346 OFF LABEL USE 412 0.0005
347 HYPERPHOSPHATAEMIA 1 0.0005
348 FACIAL PALSY 1 0.0005
349 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
350 PRODUCT LABEL ISSUE 3 0.0004
351 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
352 DISTRIBUTIVE SHOCK 1 0.0004
353 SHOCK 10 0.0004
354 UNRESPONSIVE TO STIMULI 11 0.0004
355 VENTRICULAR TACHYCARDIA 7 0.0004
356 PULSE ABSENT 2 0.0004
357 CEREBROVASCULAR ACCIDENT 71 0.0004
358 OXYGEN CONSUMPTION INCREASED 1 0.0004
359 LACUNAR INFARCTION 1 0.0004
360 ATELECTASIS 4 0.0004
361 STARING 1 0.0004
362 WRONG DOSE 1 0.0004
363 MOUTH HAEMORRHAGE 3 0.0004
364 RETROPERITONEAL HAEMORRHAGE 1 0.0004
365 CARDIAC ARREST 33 0.0004
366 VASODILATATION 1 0.0004
367 RETINAL ARTERY OCCLUSION 1 0.0004
368 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
369 MEAN CELL VOLUME INCREASED 1 0.0004
370 AORTIC ARTERIOSCLEROSIS 1 0.0004
371 EJECTION FRACTION DECREASED 6 0.0004
372 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
373 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
374 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
375 INCORRECT PRODUCT STORAGE 5 0.0004
376 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
377 GINGIVAL BLEEDING 5 0.0004
378 POST PROCEDURAL COMPLICATION 7 0.0004
379 EMBOLISM 3 0.0004
380 NECROSIS 2 0.0004
381 HAEMOPTYSIS 10 0.0004
382 ENDOTRACHEAL INTUBATION 1 0.0004
383 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
384 ACUTE PULMONARY OEDEMA 2 0.0004
385 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
386 CEREBRAL THROMBOSIS 1 0.0004
387 SWOLLEN TONGUE 11 0.0004
388 PARAPLEGIA 1 0.0003
389 STRESS CARDIOMYOPATHY 2 0.0003
390 BLOOD CULTURE POSITIVE 1 0.0003
391 EMBOLISM VENOUS 1 0.0003
392 DIABETIC FOOT 1 0.0003
393 UROSEPSIS 3 0.0003
394 VENTRICULAR HYPOKINESIA 1 0.0003
395 GASTROINTESTINAL HAEMORRHAGE 26 0.0003
396 HYPOVENTILATION 1 0.0003
397 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
398 BRADYCARDIA 16 0.0003
399 PRODUCT ADMINISTRATION ERROR 6 0.0003
400 TACHYPNOEA 4 0.0003
401 SUDDEN CARDIAC DEATH 1 0.0003
402 DYSARTHRIA 11 0.0003
403 BRONCHOPNEUMONIA 1 0.0003
404 LEFT VENTRICULAR FAILURE 1 0.0003
405 MULTI-ORGAN FAILURE 5 0.0003
406 ENCEPHALITIS 2 0.0003
407 BRONCHIOLITIS 1 0.0003
408 THROMBOTIC THROMBOCYTOPENIC PURPURA 1 0.0003
409 HEART DISEASE CONGENITAL 1 0.0003
410 CAROTID ARTERY OCCLUSION 1 0.0003
411 UTERINE LEIOMYOMA 2 0.0003
412 COMA 13 0.0003
413 HAEMOGLOBIN DECREASED 28 0.0003
414 CARDIAC DYSFUNCTION 1 0.0003
415 IMPULSIVE BEHAVIOUR 1 0.0003
416 TROPONIN INCREASED 2 0.0003
417 HAEMODYNAMIC INSTABILITY 2 0.0003
418 COMMUNICATION DISORDER 1 0.0003
419 METASTASES TO LUNG 3 0.0003
420 REHABILITATION THERAPY 1 0.0003
421 CARDIOPULMONARY FAILURE 1 0.0003
422 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
423 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
424 RESPIRATORY ACIDOSIS 1 0.0003
425 CEREBRAL ATROPHY 1 0.0003
426 AZOTAEMIA 1 0.0003
427 NOCTURIA 3 0.0002
428 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
429 PERIPHERAL VENOUS DISEASE 1 0.0002
430 ARTHRITIS BACTERIAL 1 0.0002
431 EXTRAVASATION 1 0.0002
432 INJECTION SITE EXTRAVASATION 3 0.0002
433 AORTIC VALVE INCOMPETENCE 1 0.0002
434 CIRCULATORY COLLAPSE 4 0.0002
435 CARDIAC FAILURE CHRONIC 1 0.0002
436 LUNG INFILTRATION 2 0.0002
437 NERVOUS SYSTEM DISORDER 7 0.0002
438 PULMONARY OEDEMA 10 0.0002
439 RESPIRATORY FAILURE 16 0.0002
440 CORONARY ARTERY OCCLUSION 3 0.0002
441 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
442 LOCALISED OEDEMA 1 0.0002
443 LIP SWELLING 7 0.0002
444 HYPOVOLAEMIC SHOCK 1 0.0002
445 GASTROINTESTINAL TOXICITY 1 0.0002
446 GUILLAIN-BARRE SYNDROME 1 0.0002
447 PANCREATIC DISORDER 1 0.0002
448 INFLAMMATORY MARKER INCREASED 1 0.0002
449 ABDOMINAL TENDERNESS 1 0.0002
450 BRAIN INJURY 2 0.0002
451 HYPOXIA 7 0.0002
452 KLEBSIELLA INFECTION 1 0.0002
453 DRUG DISPENSING ERROR 3 0.0002
454 ENDOCARDITIS 1 0.0002
455 HYPOTENSION 39 0.0002
456 TRISMUS 1 0.0002
457 CARDIO-RESPIRATORY ARREST 8 0.0002
458 EPISTAXIS 14 0.0002
459 BEHAVIOUR DISORDER 1 0.0002
460 PULMONARY THROMBOSIS 2 0.0002
461 NONSPECIFIC REACTION 1 0.0002
462 COAGULOPATHY 3 0.0002
463 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
464 VISUAL DISTURBANCE 1 0.0002
465 MOUTH SWELLING 1 0.0002
466 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
467 ATAXIA 2 0.0002
468 CHOLECYSTITIS 2 0.0002
469 CARDIAC PACEMAKER INSERTION 1 0.0002
470 PROTHROMBIN TIME PROLONGED 1 0.0002
471 POLYNEUROPATHY 2 0.0002
472 HYPERGLYCAEMIA 6 0.0002
473 PRESYNCOPE 4 0.0002
474 PLEURAL EFFUSION 10 0.0002
475 AGITATION 12 0.0002
476 ANAPHYLACTIC REACTION 9 0.0002
477 OLIGURIA 1 0.0002
478 INFUSION SITE EXTRAVASATION 1 0.0002
479 MYDRIASIS 2 0.0002
480 PROCTALGIA 1 0.0002
481 POOR QUALITY DRUG ADMINISTERED 1 0.0002
482 ANGINA UNSTABLE 1 0.0002
483 HEPATITIS ACUTE 1 0.0002
484 HAEMATOCRIT DECREASED 3 0.0002
485 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
486 BLOOD PRESSURE ABNORMAL 3 0.0002
487 CARDIAC FAILURE ACUTE 1 0.0001
488 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
489 TASTE DISORDER 3 0.0001
490 ECCHYMOSIS 1 0.0001
491 RESPIRATORY ARREST 4 0.0001
492 RESPIRATORY DISTRESS 4 0.0001
493 LYMPHOEDEMA 1 0.0001
494 MYOCARDIAL INFARCTION 25 0.0001
495 DUODENAL ULCER 1 0.0001
496 EATING DISORDER 3 0.0001
497 CHEST PAIN 26 0.0001
498 METASTASIS 1 0.0001
499 VISUAL FIELD DEFECT 1 0.0001
500 HYPOKINESIA 2 0.0001
501 PRODUCT DISPENSING ERROR 3 0.0001
502 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
503 THROMBOSIS 11 0.0001
504 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
505 CEREBRAL DISORDER 1 0.0001
506 HYDRONEPHROSIS 1 0.0001
507 CORONARY ARTERY DISEASE 4 0.0001
508 HYPERTHERMIA 1 0.0001
509 ACIDOSIS 1 0.0001
510 BLOOD PRESSURE INCREASED 20 0.0001
511 DISSOCIATION 1 0.0001
512 PROCEDURAL COMPLICATION 1 0.0001
513 DRUG ADMINISTRATION ERROR 4 0.0001
514 SEIZURE 15 0.0001
515 ATRIOVENTRICULAR BLOCK 1 0.0001
516 PRODUCT USE COMPLAINT 2 0.0001
517 RENAL CYST 1 0.0001
518 TRICUSPID VALVE INCOMPETENCE 1 0.0001
519 TACHYCARDIA 11 0.0001
520 DEEP VEIN THROMBOSIS 8 0.0001
521 DECUBITUS ULCER 1 0.0001
522 ASPHYXIA 1 0.0001
523 POLYURIA 1 0.0001
524 PRODUCT COMPLAINT 3 0.0001
525 HAEMATURIA 4 0.0001
526 MYOPATHY 1 0.0001
527 PULMONARY EMBOLISM 11 0.0001
528 URINE OUTPUT DECREASED 1 0.0001
529 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
530 RESPIRATORY RATE INCREASED 1 0.0001
531 CARDIOTOXICITY 1 0.0001
532 HAEMARTHROSIS 1 0.0001
533 PNEUMONIA BACTERIAL 1 0.0001
534 RETINAL DETACHMENT 1 0.0001
535 MENTAL STATUS CHANGES 3 0.0001
536 ARTERIOSCLEROSIS 1 0.0001
537 ARRHYTHMIA 5 0.0001
538 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
539 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
540 DRUG PRESCRIBING ERROR 2 0.0001
541 DIZZINESS POSTURAL 1 0.0001
542 BODY TEMPERATURE DECREASED 1 0.0001
543 HOSPICE CARE 1 0.0001
544 DRUG INTERACTION 16 0.0001
545 PRESCRIBED UNDERDOSE 2 0.0001
546 HYPOTONIA 1 0.0001
547 CARDIAC FAILURE 8 0.0001
548 TREATMENT FAILURE 8 0.0001
549 VENTRICULAR EXTRASYSTOLES 1 0.0001
550 SUDDEN DEATH 1 0.0001
551 RENAL FAILURE ACUTE 4 0.0001
552 DEATH 81 0.0001
553 SKIN LACERATION 1 0.0001
554 PRODUCT STORAGE ERROR 8 0.0001
555 WOUND INFECTION 1 0.0001
556 MELAENA 2 0.0001
557 PNEUMONIA 29 0.0001
558 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
559 INTESTINAL PERFORATION 1 0.0001
560 NEPHROPATHY TOXIC 1 0.0001
561 MITRAL VALVE INCOMPETENCE 1 0.0001
562 PRODUCT AVAILABILITY ISSUE 2 0.0001
563 CONVULSION 5 0.0001
564 GASTRIC HAEMORRHAGE 1 0.0001
565 PERICARDIAL EFFUSION 2 0.0001
566 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
567 VASCULITIS 1 0.0001
568 LYMPHADENOPATHY 3 0.0001
569 BACTERAEMIA 1 0.0001
570 MUSCLE RIGIDITY 1 0.0001
571 INCORRECT DOSE ADMINISTERED 19 0.0001
572 RENAL FAILURE 11 0.0001
573 ENCEPHALOPATHY 2 0.0001
574 HAIR COLOUR CHANGES 1 0.0001
575 HYPOAESTHESIA 12 0.0001
576 SECRETION DISCHARGE 1 0.0001
577 CARDIOVASCULAR DISORDER 2 0.0001
578 ANAPHYLACTIC SHOCK 2 0.0001
579 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
580 SWELLING FACE 5 0.0001
581 ANHEDONIA 2 0.0001
582 HYPERTENSION 16 0.0001
583 CARDIAC FAILURE CONGESTIVE 6 0.0001
584 FEAR 2 0.0001
585 DRUG TOXICITY 1 0.0001
586 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
587 ATRIAL FIBRILLATION 7 0.0001
588 COORDINATION ABNORMAL 1 0.0001
589 THROMBOCYTOPENIA 8 0.0001
590 BLINDNESS UNILATERAL 1 0.0001
591 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
592 PARALYSIS 1 0.0001
593 LETHARGY 4 0.0001
594 SEPTIC SHOCK 3 0.0001
595 INJECTION SITE HAEMATOMA 1 0.0001
596 COLITIS ULCERATIVE 3 0.0001
597 COLON CANCER 1 0.0001
598 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
599 OVERDOSE 14 0.0001
600 EMOTIONAL DISORDER 2 0.0001
601 THERAPY PARTIAL RESPONDER 1 0.0001
602 BRAIN FOG 1 0.0001
603 DYSPHAGIA 6 0.0001
604 HEAD INJURY 2 0.0001
605 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
606 PNEUMOTHORAX 1 0.0001
607 SEPSIS 7 0.0001
608 SENSORY DISTURBANCE 1 0.0001
609 HIP FRACTURE 2 0.0001
610 CONFUSIONAL STATE 10 0.0001
611 EYE DISORDER 2 0.0001
612 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
613 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
614 VISUAL ACUITY REDUCED 2 0.0001
615 EXPIRED PRODUCT ADMINISTERED 2 0.0001
616 URINARY RETENTION 2 0.0001
617 PERICARDITIS 1 0.0001
618 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
619 PRODUCT QUALITY ISSUE 8 0.0001
620 ANAEMIA 11 0.0001
621 ORTHOSTATIC HYPOTENSION 1 0.0001
622 SYRINGE ISSUE 1 0.0001
623 COLD SWEAT 1 0.0001
624 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
625 OSTEOMYELITIS 1 0.0001
626 RESTLESSNESS 2 0.0001
627 LOSS OF CONSCIOUSNESS 7 0.0001
628 DRUG INEFFECTIVE 72 0.0001
629 BLOOD GLUCOSE ABNORMAL 1 0.0001
630 HEPATIC STEATOSIS 1 0.0001
631 OXYGEN SATURATION DECREASED 3 0.0001
632 PHOTOPHOBIA 1 0.0001
633 BLOOD URINE PRESENT 1 0.0001
634 SLEEP APNOEA SYNDROME 1 0.0001
635 MIGRAINE 5 0.0001
636 ACUTE KIDNEY INJURY 8 0.0001
637 ACUTE RESPIRATORY FAILURE 1 0.0001
638 CHOKING 1 0.0001
639 DISABILITY 1 0.0001
640 SPINAL FRACTURE 1 0.0000
641 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
642 PLATELET COUNT DECREASED 5 0.0000
643 RECTAL HAEMORRHAGE 2 0.0000
644 HEADACHE 29 0.0000
645 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
646 PRODUCT PRESCRIBING ISSUE 1 0.0000
647 THERAPY NON-RESPONDER 2 0.0000
648 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
649 MUSCLE TWITCHING 1 0.0000
650 BURNING SENSATION 3 0.0000
651 SWELLING 4 0.0000
652 INJURY 3 0.0000
653 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
654 PRODUCT PRESCRIBING ERROR 1 0.0000
655 LUNG DISORDER 2 0.0000
656 UNEVALUABLE EVENT 3 0.0000
657 INFLAMMATION 2 0.0000
658 DIPLOPIA 1 0.0000
659 BREAST CANCER FEMALE 1 0.0000
660 HAEMATOCHEZIA 2 0.0000
661 CONDITION AGGRAVATED 11 0.0000
662 RENAL IMPAIRMENT 3 0.0000
663 MUSCULAR WEAKNESS 4 0.0000
664 RED BLOOD CELL COUNT DECREASED 1 0.0000
665 ANGINA PECTORIS 1 0.0000
666 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
667 PANCREATIC CARCINOMA 1 0.0000
668 NEEDLE ISSUE 1 0.0000
669 RENAL INJURY 1 0.0000
670 ADVERSE DRUG REACTION 3 0.0000
671 HEPATIC FAILURE 1 0.0000
672 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
673 ILL-DEFINED DISORDER 2 0.0000
674 OEDEMA PERIPHERAL 4 0.0000
675 EPILEPSY 1 0.0000
676 HYPERSENSITIVITY 6 0.0000
677 ASTHENIA 12 0.0000
678 CONTUSION 3 0.0000
679 MOVEMENT DISORDER 1 0.0000
680 AMNESIA 2 0.0000
681 STAPHYLOCOCCAL INFECTION 1 0.0000
682 BLOOD PRESSURE DECREASED 2 0.0000
683 FUNGAL INFECTION 1 0.0000
684 NEOPLASM MALIGNANT 2 0.0000
685 URTICARIA 5 0.0000
686 TYPE 2 DIABETES MELLITUS 1 0.0000
687 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
688 NIGHTMARE 1 0.0000
689 DEVICE USE ERROR 1 0.0000
690 HYPERKALAEMIA 1 0.0000
691 HEART RATE DECREASED 1 0.0000
692 DEVICE MALFUNCTION 2 0.0000
693 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
694 THERAPY INTERRUPTED 2 0.0000
695 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
696 C-REACTIVE PROTEIN INCREASED 1 0.0000
697 ACCIDENTAL OVERDOSE 1 0.0000
698 EYE SWELLING 1 0.0000
699 HEPATIC FUNCTION ABNORMAL 1 0.0000
700 CHRONIC KIDNEY DISEASE 2 0.0000
701 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
702 VOMITING 12 0.0000
703 DISORIENTATION 1 0.0000
704 INJECTION SITE HAEMORRHAGE 2 0.0000
705 EXTRA DOSE ADMINISTERED 1 0.0000
706 DYSKINESIA 1 0.0000
707 LUNG NEOPLASM MALIGNANT 1 0.0000
708 RHABDOMYOLYSIS 1 0.0000
709 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
710 MEMORY IMPAIRMENT 3 0.0000
711 SKIN DISCOLOURATION 1 0.0000
712 HYPOKALAEMIA 1 0.0000
713 WEIGHT DECREASED 6 0.0000
714 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
715 DISEASE RECURRENCE 1 0.0000
716 PRODUCTIVE COUGH 1 0.0000
717 RASH ERYTHEMATOUS 1 0.0000
718 DRUG INTOLERANCE 2 0.0000
719 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
720 CELLULITIS 1 0.0000
721 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
722 PARAESTHESIA 3 0.0000
723 DRUG EFFECT DECREASED 1 0.0000
724 OEDEMA 1 0.0000
725 HYPONATRAEMIA 1 0.0000
726 EYE PAIN 1 0.0000
727 DYSPHONIA 1 0.0000
728 DISEASE PROGRESSION 2 0.0000
729 WHEEZING 1 0.0000
730 FEELING ABNORMAL 4 0.0000
731 MUSCLE SPASMS 3 0.0000
732 HYPERHIDROSIS 2 0.0000
733 BLOOD CREATININE INCREASED 1 0.0000
734 NAUSEA 12 0.0000
735 INFUSION RELATED REACTION 1 0.0000
736 PYREXIA 5 0.0000
737 DYSPNOEA 8 0.0000
738 ANXIETY 4 0.0000
739 BRONCHITIS 1 0.0000
740 HALLUCINATION 1 0.0000
741 ABDOMINAL PAIN 3 0.0000
742 DIZZINESS 6 0.0000
743 URINARY TRACT INFECTION 2 0.0000
744 BALANCE DISORDER 1 0.0000
745 INTENTIONAL PRODUCT MISUSE 1 0.0000
746 MUSCULOSKELETAL STIFFNESS 1 0.0000
747 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
748 GASTROINTESTINAL DISORDER 1 0.0000
749 OROPHARYNGEAL PAIN 1 0.0000
750 CARDIAC DISORDER 1 0.0000
751 PRODUCT USE ISSUE 2 0.0000
752 PRURITUS 4 0.0000
753 PAIN IN EXTREMITY 3 0.0000
754 HEART RATE INCREASED 1 0.0000
755 SOMNOLENCE 2 0.0000
756 FLUSHING 1 0.0000
757 CHEST DISCOMFORT 1 0.0000
758 RASH 4 0.0000
759 CONSTIPATION 2 0.0000
760 FALL 3 0.0000
761 RHEUMATOID ARTHRITIS 1 0.0000
762 DEPRESSION 2 0.0000
763 PALPITATIONS 1 0.0000
764 CHILLS 1 0.0000
765 EMOTIONAL DISTRESS 1 0.0000
766 DEHYDRATION 1 0.0000
767 VISION BLURRED 1 0.0000
768 COUGH 2 0.0000
769 INFECTION 1 0.0000
770 PRODUCT DOSE OMISSION ISSUE 2 0.0000
771 PAIN 4 0.0000
772 HOSPITALISATION 1 0.0000
773 FATIGUE 5 0.0000
774 DIARRHOEA 4 0.0000
775 TREMOR 1 0.0000
776 BLOOD GLUCOSE INCREASED 1 0.0000
777 GAIT DISTURBANCE 1 0.0000
778 ALOPECIA 1 0.0000
779 ERYTHEMA 1 0.0000
780 ABDOMINAL PAIN UPPER 1 0.0000
781 ARTHRALGIA 2 0.0000
782 BACK PAIN 1 0.0000
783 MALAISE 1 0.0000